Royce & Associates’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,009
Closed -$185K 944
2023
Q1
$185K Sell
10,009
-151,854
-94% -$2.85M ﹤0.01% 891
2022
Q4
$2.47M Buy
+161,863
New +$2.31M 0.03% 613
2020
Q4
Sell
-46,962
Closed -$1.84M 1025
2020
Q3
$1.84M Hold
46,962
0.02% 693
2020
Q2
$1.82M Buy
46,962
+2,162
+5% +$73.1K 0.02% 683
2020
Q1
$1.5M Hold
44,800
0.02% 661
2019
Q4
$1.46M Hold
44,800
0.01% 754
2019
Q3
$1.53M Sell
44,800
-984
-2% -$34.1K 0.01% 751
2019
Q2
$1.42M Buy
45,784
+984
+2% +$29K 0.01% 788
2019
Q1
$1.29M Sell
44,800
-36,000
-45% -$1.09M 0.01% 822
2018
Q4
$2.3M Buy
80,800
+36,000
+80% +$1.13M 0.02% 692
2018
Q3
$1.6M Sell
44,800
-275,362
-86% -$11.7M 0.01% 863
2018
Q2
$12.8M Sell
320,162
-11,706
-4% -$432K 0.09% 328
2018
Q1
$11.1M Sell
331,868
-23
-0% -$693 0.08% 356
2017
Q4
$10.2M Sell
331,891
-71,914
-18% -$2.18M 0.07% 384
2017
Q3
$11.7M Buy
403,805
+338
+0.1% +$8.69K 0.08% 345
2017
Q2
$10.5M Hold
403,467
0.07% 382
2017
Q1
$9.92M Buy
403,467
+298,934
+286% +$7.32M 0.06% 387
2016
Q4
$2.59M Sell
104,533
-1,734
-2% -$38.5K 0.02% 754
2016
Q3
$2.23M Sell
106,267
-4,000
-4% -$85.6K 0.01% 775
2016
Q2
$2.33M Buy
110,267
+14,000
+15% +$261K 0.02% 779
2016
Q1
$1.82M Buy
+96,267
New +$1.83M 0.01% 843
2013
Q4
Sell
-4,000
Closed -$61K 1462
2013
Q3
$61K Hold
4,000
﹤0.01% 1392
2013
Q2
$56K Buy
+4,000
New +$52.8K ﹤0.01% 1373

Other funds holding NEOG

Royce & Associates's NEOG Position: Q2 2023 in Review

Royce & Associates sold out of Neogen (NEOG) in Q2 2023, closing a stake of 10,009 shares — an estimated $185K sold.

Royce & Associates first reported a position in NEOG in Q2 2013 and held it in 23 quarters. The position peaked at $12.8M in Q2 2018. 341 funds tracked by Wall St. Rank hold NEOG as of Q2 2023.

  • Royce & Associates reported no remaining Neogen position as of Q2 2023 after selling out during the quarter.
  • Royce & Associates sold 10,009 Neogen shares in Q2 2023, an estimated $185K.
  • Royce & Associates first reported a position in Neogen in Q2 2013 and held it in 23 quarters.
  • Royce & Associates's Neogen position peaked at $12.8M in Q2 2018.
  • 341 funds tracked by Wall St. Rank held Neogen as of Q2 2023.

Based on Royce & Associates's 13F filing for Q2 2023, filed 7 Aug 2023.